IndraLab

Statements

KB130015 activates KCNH2. 9 / 9
| 9
reach
"Increasing KB130015 concentrations enhanced hERG1 outward current amplitudes at -20 mV (XREF_FIG)."
20097192
reach
"KB130015 accelerates hERG1 activation gating."
20097192
reach
"As shown in XREF_FIG, hERG1 activation is significantly accelerated by KB130015 in a voltage dependent manner (e.g., 3.8-fold at -20 mV compared to 2.4-fold at +40 mV)."
20097192
reach
"We conclude that KB130015 activates hERG1 channels via a novel mechanism that is not directed to removal of inactivation or to slow-down of deactivation but rather involves an acceleration of hERG1 activation."
20097192
reach
"We conclude that MTx and KB130015 synergically activate hERG1 channels, requiring the existence of at least two functionally coupled activator sites."
20097192
reach
"The effective concentration in the micromolar range of hERG1 activation by KB130015 is comparable to that of RPR260243, NS1643, and PD-118057, whereas mallotoxin, the only known natural hERG1 activator, is active even in the sub-micromolar range."
20097192
reach
"While we can not exclude that KB130015 binding in the central cavity partly underlies the inhibitory effects of KB130015 and its competition with pore blockers, the lack of use-dependence for hERG1 activation by KB130015 requires an " activator " site outside the inner cavity."
20097192
reach
"We assume that KB130015 mediated hERG1 activation depends on conformational transitions that require a tyrosine at position 652."
20097192
reach
"KB130015 activates and blocks hERG1 channels independently of inactivation gating."
20097192